Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Potestio

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
Dermatologic Therapy|October 13, 2022
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysisCataldo Patruno, Luca Potestio, Gabriella Fabbrocini, et al.
Journal of Cosmetic Dermatology|March 31, 2026
Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe AcneNello Tommasino, Maria Carmela Annunziata, Luca Potestio, et al.
Clinical, Cosmetic and Investigational Dermatology|December 12, 2025
Efficacy and Safety of Hormonal Therapies for Acne: A Narrative ReviewNello Tommasino, Maria Carmela Annunziata, Luca Potestio, et al.
Italian Journal of Dermatology and Venereology|June 17, 2024
Drug-induced photosensitivity associated with anticancer therapiesDavide Fattore, Luca Potestio, Ariadna Ortiz Brugués, et al.
Clinical, Cosmetic and Investigational Dermatology|January 13, 2025
Hypergammaglobulinemia in Hidradenitis Suppurativa Patients: A New Emerging AssociationFabrizio Martora, Teresa Battista, Antonella Giordano, et al.
Dermatologic Therapy|April 19, 2022
Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life studyMatteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Psoriasis (Auckland, N.Z.)|April 20, 2023
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for PsoriasisLuca Potestio, Fabrizio Martora, Gabriella Fabbrocini, et al.
Dermatology and Therapy|April 9, 2024
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular ComorbiditiesLuca Potestio, Nello Tommasino, Giuseppe Lauletta, et al.
Expert Opinion on Drug Safety|December 17, 2022
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledgeAngelo Ruggiero, Elisa Camela, Luca Potestio, et al.
Expert Opinion on Investigational Drugs|May 27, 2023
The holistic approach to psoriasis patients with comorbidities: the role of investigational drugsElisa Camela, Luca Potestio, Gabriella Fabbrocini, et al.
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
Dermatologic Therapy|October 13, 2022
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysisCataldo Patruno, Luca Potestio, Gabriella Fabbrocini, et al.
Journal of Cosmetic Dermatology|March 31, 2026
Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe AcneNello Tommasino, Maria Carmela Annunziata, Luca Potestio, et al.
Clinical, Cosmetic and Investigational Dermatology|December 12, 2025
Efficacy and Safety of Hormonal Therapies for Acne: A Narrative ReviewNello Tommasino, Maria Carmela Annunziata, Luca Potestio, et al.
Italian Journal of Dermatology and Venereology|June 17, 2024
Drug-induced photosensitivity associated with anticancer therapiesDavide Fattore, Luca Potestio, Ariadna Ortiz Brugués, et al.
Clinical, Cosmetic and Investigational Dermatology|January 13, 2025
Hypergammaglobulinemia in Hidradenitis Suppurativa Patients: A New Emerging AssociationFabrizio Martora, Teresa Battista, Antonella Giordano, et al.
Dermatologic Therapy|April 19, 2022
Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life studyMatteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Psoriasis (Auckland, N.Z.)|April 20, 2023
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for PsoriasisLuca Potestio, Fabrizio Martora, Gabriella Fabbrocini, et al.
Dermatology and Therapy|April 9, 2024
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular ComorbiditiesLuca Potestio, Nello Tommasino, Giuseppe Lauletta, et al.
Expert Opinion on Drug Safety|December 17, 2022
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledgeAngelo Ruggiero, Elisa Camela, Luca Potestio, et al.
Expert Opinion on Investigational Drugs|May 27, 2023
The holistic approach to psoriasis patients with comorbidities: the role of investigational drugsElisa Camela, Luca Potestio, Gabriella Fabbrocini, et al.
Pageof 14